Literature DB >> 10789832

Effects of A1 and A2 adenosine receptor antagonists on the induction and reversal of long-term potentiation in guinea pig hippocampal slices of CA1 neurons.

S Fujii1, H Kato, K Ito, S Itoh, Y Yamazaki, H Sasaki, Y Kuroda.   

Abstract

1. Using simultaneous recordings of the field EPSP and the population spike in the CA1 neurons of guinea pig hippocampal slices, we confirmed that delivery of a high-frequency stimulation (tetanus: 100 pulses at 100 Hz) produced robust long-term potentiation of synaptic efficacy (LTP) in two independent components, a synaptic component that increases field excitatory postsynaptic potentials (EPSPs) and a component that results in a larger population spike amplitude for a given EPSP size (E-S potentiation). 2. In the same cells, reversal of LTP (depotentiation; DP) in the field EPSP and in the E-S component is achieved by delivering low-frequency afferent stimulation (LFS: 1 Hz, 1000 pulses) 20 min after the tetanus. 3. When the tetanus or LFS was applied to CA1 inputs in the presence of an adenosine A1 receptor antagonist, 8-cyclopentyltheophylline (1 microM), the field EPSP was enhances in LTP and attenuated in DP, while the E-S relationship was not significantly affected in either LTP or DP. 4. When similar experiments were performed using an A2 receptor antagonist, CP-66713 (10 microM), the field EPSP was blocked in LTP but facilitated in DP, while E-S potentiation was enhanced during both LTP and DP. 5. The results show that endogenous adenosine, acting via A1 or A2 receptors, modulates both the synaptic and the E-S components of the induction and reversal of LTP. Based on the results, we discuss the key issue of the contribution of these receptors to the dynamics of neuronal plasticity modification in hippocampal CA1 neurons.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10789832     DOI: 10.1023/a:1007014226224

Source DB:  PubMed          Journal:  Cell Mol Neurobiol        ISSN: 0272-4340            Impact factor:   5.046


  41 in total

1.  Long-term potentiation of the perforant path-granule cell synapse in the rat hippocampus.

Authors:  R M Douglas; G V Goddard
Journal:  Brain Res       Date:  1975-03-21       Impact factor: 3.252

2.  Stimulation-dependent release of 3H-adenosine derivatives from central axon terminals to target neurones.

Authors:  P Schubert; K Lee; M West; S Deadwyler; G Lynch
Journal:  Nature       Date:  1976-04-08       Impact factor: 49.962

3.  Adenosine A2 receptor antagonist facilitates the reversal of long-term potentiation (depotentiation) of evoked postsynaptic potentials but inhibits that of population spikes in hippocampal CA1 neurons.

Authors:  S Fujii; A Wakizaka; Y Sekino; Y Kuroda; K Ito; H Miyakawa; H Kato
Journal:  Neurosci Lett       Date:  1992-12-14       Impact factor: 3.046

4.  Stable depression of potentiated synaptic responses in the hippocampus with 1-5 Hz stimulation.

Authors:  U Staubli; G Lynch
Journal:  Brain Res       Date:  1990-04-09       Impact factor: 3.252

5.  Changes in translation of synaptic excitation to dentate granule cell discharge accompanying long-term potentiation. II. An evaluation of mechanisms utilizing dentate gyrus dually innervated by surviving ipsilateral and sprouted crossed temporodentate inputs.

Authors:  R C Wilson; W B Levy; O Steward
Journal:  J Neurophysiol       Date:  1981-08       Impact factor: 2.714

6.  The effects of repetitive low frequency stimulation on control and "potentiated" synaptic responses in the hippocampus.

Authors:  G Barrionuevo; F Schottler; G Lynch
Journal:  Life Sci       Date:  1980-12-15       Impact factor: 5.037

7.  Spatial exploration induces a persistent reversal of long-term potentiation in rat hippocampus.

Authors:  L Xu; R Anwyl; M J Rowan
Journal:  Nature       Date:  1998-08-27       Impact factor: 49.962

8.  Adenosine A1 receptors inhibit adenylate cyclase activity and neurotransmitter release and hyperpolarize pyramidal neurons in rat hippocampus.

Authors:  T V Dunwiddie; B B Fredholm
Journal:  J Pharmacol Exp Ther       Date:  1989-04       Impact factor: 4.030

9.  Adenosine receptors mediating cyclic AMP production in the rat hippocampus.

Authors:  B B Fredholm; B Jonzon; E Lindgren; K Lindström
Journal:  J Neurochem       Date:  1982-07       Impact factor: 5.372

10.  Adenosine (A2) antagonist inhibits induction of long-term potentiation of evoked synaptic potentials but not of the population spike in hippocampal CA1 neurons.

Authors:  Y Sekino; K Ito; H Miyakawa; H Kato; Y Kuroda
Journal:  Biochem Biophys Res Commun       Date:  1991-12-31       Impact factor: 3.575

View more
  6 in total

1.  Temperoammonic Stimulation Depotentiates Schaffer Collateral LTP via p38 MAPK Downstream of Adenosine A1 Receptors.

Authors:  Yukitoshi Izumi; Charles F Zorumski
Journal:  J Neurosci       Date:  2019-01-08       Impact factor: 6.167

2.  Direct cortical inputs erase long-term potentiation at Schaffer collateral synapses.

Authors:  Yukitoshi Izumi; Charles F Zorumski
Journal:  J Neurosci       Date:  2008-09-17       Impact factor: 6.167

3.  Superior working memory and behavioural habituation but diminished psychomotor coordination in mice lacking the ecto-5'-nucleotidase (CD73) gene.

Authors:  Armin Zlomuzica; Sandra Burghoff; Jürgen Schrader; Ekrem Dere
Journal:  Purinergic Signal       Date:  2012-12-29       Impact factor: 3.765

4.  Gamma-aminobutyric acid type A receptors modulate cAMP-mediated long-term potentiation and long-term depression at monosynaptic CA3-CA1 synapses.

Authors:  T P Yu; S McKinney; H A Lester; N Davidson
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-10       Impact factor: 11.205

5.  NMDA receptor-mediated extracellular adenosine accumulation is blocked by phosphatase 1/2A inhibitors.

Authors:  Yin Lu; Paul A Rosenberg
Journal:  Brain Res       Date:  2007-05-04       Impact factor: 3.252

6.  The nervous system and metabolic dysregulation: emerging evidence converges on ketogenic diet therapy.

Authors:  David N Ruskin; Susan A Masino
Journal:  Front Neurosci       Date:  2012-03-26       Impact factor: 4.677

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.